Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Evolent Health
EVH
Evolent Health
Value-based Care And Digital Automation Will Expand Future Opportunities
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 13 Analysts
Published
07 May 25
Updated
15 Aug 25
8
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
US$15.31
37.3% undervalued
intrinsic discount
15 Aug
US$9.60
Loading
1Y
-70.9%
7D
3.2%
Author's Valuation
US$15.3
37.3% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
US$15.3
37.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-504m
3b
2014
2017
2020
2023
2025
2026
2028
Revenue US$3.0b
Earnings US$1.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
11.96%
Healthtech revenue growth rate
4.12%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
9.91%
Calculation
US$1.74m
Earnings '28
x
1390.17x
PE Ratio '28
=
US$2.42b
Market Cap '28
US$2.42b
Market Cap '28
/
119.70m
No. shares '28
=
US$20.18
Share Price '28
US$20.18
Share Price '28
Discounted to 2025 @ 9.87% p.a.
=
US$15.22
Fair Value '25